Conmed (CNMD) Return on Invested Capital (2016 - 2025)
Conmed (CNMD) has disclosed Return on Invested Capital for 6 consecutive years, with 0.73% as the latest value for Q4 2017.
- For the quarter ending Q4 2017, Return on Invested Capital rose 36.0% year-over-year to 0.73%, compared with a TTM value of 0.73% through Dec 2017, up 36.0%, and an annual FY2025 reading of 0.06%, down 10.0% over the prior year.
- Return on Invested Capital was 0.73% for Q4 2017 at Conmed, up from 0.69% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.73% in Q4 2017 and bottomed at 0.36% in Q3 2016.
- Average Return on Invested Capital over 5 years is 0.58%, with a median of 0.6% recorded in 2013.
- The sharpest move saw Return on Invested Capital dropped -27bps in 2016, then surged 36bps in 2017.
- Year by year, Return on Invested Capital stood at 0.56% in 2013, then decreased by -2bps to 0.55% in 2014, then dropped by -7bps to 0.51% in 2015, then dropped by -27bps to 0.37% in 2016, then soared by 96bps to 0.73% in 2017.
- Business Quant data shows Return on Invested Capital for CNMD at 0.73% in Q4 2017, 0.69% in Q3 2017, and 0.69% in Q2 2017.